Rajarshi Roy

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial

Sun Young Rha, Do‐Youn Oh, Patricio Yañez et al. · The Lancet Oncology · 2023 · 521 citations

Chemotherapy Versus Placebo, Gastrointestinal Oncology, Medicine +8

Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial

T. Crosby, Stephen Falk, Simon Gollins et al. · The Lancet Oncology · 2013 · 378 citations · Full text

Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial

Somnath Mukherjee, John Bridgewater, Stephen Falk et al. · The Lancet Oncology · 2013 · 345 citations · Full text

Gemcitabine versus gemcitabine plus dalteparin thromboprophylaxis in pancreatic cancer

Anthony Maraveyas, Justin S. Waters, Rajarshi Roy et al. · European Journal of Cancer · 2011 · 314 citations · Full text

Pancreatic Cancer, Medicine, Gemcitabine Versus Gemcitabine +4

Efficacy of Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine on Quality of Life and Cancer Control Among Older and Frail Patients With Advanced Gastroesophageal Cancer

Peter Hall, Daniel Swinson, David A. Cairns et al. · JAMA Oncology · 2021 · 176 citations · Full text